Sglt 2 denied for failing step therapy by Aetna?

Aetna's specific coverage criteria for sglt2 are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna's Step-Therapy Requirement Blocked Your SGLT2 Inhibitor — and How to Appeal

SGLT2 inhibitors occupy a higher "step" in Aetna's diabetes and cardiorenal formulary tiers. Step-therapy protocols require that a patient try and document failure of, or intolerance to, one or more preferred agents before the plan will authorize an SGLT2 inhibitor. Denials occur when those prior-therapy records are absent from the authorization request — even when the trials actually happened.

### Why This Denial Is Commonly Overturned

Step-therapy denials succeed on appeal far more often than they fail, because the clinical history that satisfies the step requirement usually exists in the patient's chart. The prior authorization request rarely captures it in the structured format the plan requires. An appeal reframes the same clinical history into the format that maps directly to each step-therapy criterion.

In addition, most step-therapy protocols include bypass provisions. Common bypass grounds include: documented intolerance or contraindication to a required prior-step drug; a clinical condition for which the preferred agent is not indicated; or an established, stable regimen that would be disrupted by a forced step. Confirm the applicable bypass criteria by reading Aetna's published clinical policy document for SGLT2 inhibitors.

### Federal Appeal Framework

• Internal appeal (ERISA §503 / ACA): File within the deadline on the denial letter, typically 180 days. The plan must provide a full-and-fair review with clinical reviewers who were not involved in the initial denial.
• External review (ACA §2719): If the internal appeal fails, request an independent external review. The filing window is generally within four months of the final internal denial. The external reviewer's decision is binding on the plan.
• Expedited review: If delay would seriously jeopardize health, both stages may be expedited — decisions typically within 72 hours.

### Concrete Appeal Steps and Timeline

1. Pull the denial letter and find the specific step-therapy criteria not met. 2. Download Aetna's current clinical policy for SGLT2 inhibitors (available on Aetna's website) and print the step-therapy requirements and bypass provisions. 3. Gather chart records documenting every required prior-step medication: the drug name, start and stop dates, the reason for discontinuation or the response documented, and the prescriber's notes. 4. Identify whether any bypass provision applies and document it. 5. Ask your prescriber to write a medical-necessity letter that maps each step-therapy requirement to the supporting chart entry — and explicitly states which bypass provision applies if relevant. 6. Submit the internal appeal package before the deadline. Calendar the external-review window.

### Documentation to Gather

• Prior-step drug records: Pharmacy fill history, chart notes, or prescription records confirming each required drug was tried, with dates.
• Intolerance or failure documentation: Chart notes, lab results, or incident reports confirming why each prior-step drug was stopped or was insufficient.
• Diagnosis confirmation: Clinical notes establishing the diagnosis and relevant comorbidities.
• Prescriber medical-necessity letter: A signed letter that addresses each step-therapy criterion in order and cites the specific supporting record.

### Criteria-Mapping Structure

Create a two-column table in the appeal letter. Left column: each requirement stated in Aetna's step-therapy policy, quoted verbatim. Right column: the specific chart fact that satisfies it, with date and document name. Any criterion without a response is a gap the plan reviewer will use to deny again — close every gap before filing.